304 related articles for article (PubMed ID: 28814080)
1. Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition.
Jablonowski LJ; Teraphongphom NT; Wheatley MA
Mol Pharm; 2017 Oct; 14(10):3448-3456. PubMed ID: 28814080
[TBL] [Abstract][Full Text] [Related]
2. Shell effects on acoustic performance of a drug-delivery system activated by ultrasound.
Jablonowski LJ; Cochran MC; Eisenbrey JR; Teraphongphom NT; Wheatley MA
J Biomed Mater Res A; 2017 Nov; 105(11):3189-3196. PubMed ID: 28771937
[TBL] [Abstract][Full Text] [Related]
3. Manipulating multifaceted microbubble shell composition to target both TRAIL-sensitive and resistant cells.
Jablonowski LJ; Conover D; Teraphongphom NT; Wheatley MA
J Biomed Mater Res A; 2018 Jul; 106(7):1903-1915. PubMed ID: 29521001
[TBL] [Abstract][Full Text] [Related]
4. Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential.
Jablonowski LJ; Alfego D; Andorko JI; Eisenbrey JR; Teraphongphom N; Wheatley MA
Biomaterials; 2016 Oct; 103():197-206. PubMed ID: 27388945
[TBL] [Abstract][Full Text] [Related]
5. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
7. Delivery of encapsulated Doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents.
Eisenbrey JR; Soulen MC; Wheatley MA
IEEE Trans Biomed Eng; 2010 Jan; 57(1):24-8. PubMed ID: 19709952
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents.
Eisenbrey JR; Huang P; Hsu J; Wheatley MA
Ultrasonics; 2009 Dec; 49(8):628-33. PubMed ID: 19394992
[TBL] [Abstract][Full Text] [Related]
10. Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.
Yu FT; Chen X; Wang J; Qin B; Villanueva FS
Mol Pharm; 2016 Jan; 13(1):55-64. PubMed ID: 26567985
[TBL] [Abstract][Full Text] [Related]
11. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
[TBL] [Abstract][Full Text] [Related]
12. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
13. PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy.
Jiang HH; Kim TH; Lee S; Chen X; Youn YS; Lee KC
Biomaterials; 2011 Nov; 32(33):8529-37. PubMed ID: 21855130
[TBL] [Abstract][Full Text] [Related]
14. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy.
Ji G; Yang J; Chen J
Int J Pharm; 2014 May; 466(1-2):314-20. PubMed ID: 24657138
[TBL] [Abstract][Full Text] [Related]
15. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice.
Li P; Zheng Y; Ran H; Tan J; Lin Y; Zhang Q; Ren J; Wang Z
J Control Release; 2012 Sep; 162(2):349-54. PubMed ID: 22800580
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery.
Eisenbrey JR; Burstein OM; Kambhampati R; Forsberg F; Liu JB; Wheatley MA
J Control Release; 2010 Apr; 143(1):38-44. PubMed ID: 20060024
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
19. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
20. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
